-
Mashup Score: 3Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders - 2 month(s) ago
Idiopathic mast cell activation syndrome (iMCAS) is characterized by severe, episodic systemic mast cell (MC) activation and mediator-related symptoms, an event-related increase in serum tryptase levels, and response to MC-targeted therapies in the absence of underlying IgE-mediated allergy or clonal MC disorder. Studies indicating its prevalence using evidence-based diagnostic criteria are lacking.
Source: www.jaci-inpractice.orgCategories: General Medicine News, Allergy-ImmunologyTweet
In Current Issue! Low Prevalence of #Idiopathic #Mast #Cell #Activation #Syndrome Among 703 Patients With Suspected Mast Cell Disorders https://t.co/7oJ4TVCbBy https://t.co/Hr7fIRZbGo